This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Duncan Hannah: Innovator in Pharmaceutical Chemistry
Introduction
Duncan Hannah is a notable inventor based in Cambridgeshire, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on compounds that have therapeutic applications.
Latest Patents
Duncan holds a patent for "3-substituted 2-amino-indole derivatives." This invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof. The patent outlines processes for the preparation of such compounds, pharmaceutical compositions containing them, and their use in therapy.
Career Highlights
Duncan is currently associated with Takeda Pharmaceutical Company Limited, where he applies his expertise in developing new therapeutic compounds. His work has been instrumental in advancing pharmaceutical research and development.
Collaborations
Duncan has collaborated with notable colleagues, including Gregory Barker and Richard John Davenport. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Duncan Hannah's contributions to pharmaceutical chemistry exemplify the impact of innovative thinking in the development of new therapeutic solutions. His work continues to influence the field and improve patient care.